SlideShare a Scribd company logo
Chapter 4- Enzymes and Vitamins
(Part B of Enzymes)
JEMIMAH JOY I. GUARIN
Part B:
• Factors that affect enzyme activity
• Extremozymes
• Enzyme Inhibition
• Prescription Drugs that Inhibit Enzyme Activity
• Medical Uses of Enzymes
Factors that Affect Enzyme Activity
Enzyme activity- is a measure of the rate at which an enzyme converts the
substrate to products in a biochemical reaction.
• Temperature
• pH
• Substrate concentration
• Enzyme concentration
Temperature
temperature  molecules are moving faster and colliding more frequently.
temperature of an enzymatically catalyzed reaction;
the rate (velocity) of the reaction
Temperature
• Temperature increases beyond a certain point, and the increased energy begins to
cause disruptions in the tertiary structure of the enzyme  enzyme denaturation.
• Change in tertiary structure at the active site impedes catalytic
action, and the enzyme activity quickly decreases as the
temperature climbs past this point.
• Optimum temperature- is the temperature at which an enzyme
exhibits maximum activity.
Temperature
Example:
Human enzymes the optimum temperature is 37°C.
-If it exceeds 40°C, it can be a life-threatening situation because such a
temperature is sufficient to initiate enzyme denaturation.
Autoclaves- a high temperature, high-pressure vessels
Wherein super-heated stem is used to produce a
Temperature is sufficient to denature bacterial enzymes.
pH
• The pH of an enzyme’s environment can affect its activity.
• Small changes in pH can result in enzyme denaturation and subsequent loss of
catalytic activity.
• Most enzymes exhibit maximum activity over a very narrow pH range.
• Optimum pH- is the pH at which an enzyme exhibits maximum activity.
• Biochemical buffers help maintain the optimum pH for an enzyme.
• Enzyme physiological pH range: 7.0-7.5
• Exception: the digestive enzymes pepsin=2.0 ; trypsin=8.0
• A variation from normal pH can also affect substrates, causing either
Protonation or deprotonation of groups on the substrate.
Substrate Concentration
• Saturation curve- is when the concentration
of an enzyme is kept constant and the
concentration of substrate is increased.
• Each substrate must occupy an enzyme
active site for a finite amount of time, and
the products must leave the site before the
cycle can be repeated.
• Turnover number- is the number of substrate
molecules transformed per minute by one
molecule of enzyme under optimum
conditions of temperature, pH, and
saturation.
Enzyme Concentration
• The concentration of substrate in a reaction is much
higher than that of the enzyme.
• The greater the enzyme concentration, the greater
the reaction rate.
Extremozymes
• Extremophile
- is a microorganism that thrives in extreme environments,
environments in which humans and most other forms of life could not
survive.
-comes from the Latin words: extremus extreme; philia love
• The ability of extremophiles to survive under such harsh conditions is
related to the amino acid sequences present in the enzymes
(proteins) of extremophiles.
Extremozymes
Types of Extremophiles:
Acidophiles- optimal growth at pH levels of 3.0 or below.
Alkaliphiles- optimal growth at pH levels of 9.0 or above.
Halophiles- high salinity, a salinity that exceeds 0.2 M NaCl needed for growth.
Hyperthermophiles- a temperature between 80°C and 121°C needed to thrive.
Piezophiles- a high hydrostatic pressure needed for growth.
Xerophiles- extremely dry conditions needed for growth.
Cryophiles- a temperature of 15°C or lower needed for growth.
Extremozymes
-is a microbial enzyme active at conditions that would inactivate human enzymes
as well as enzymes present in other types of higher organisms.
Extremozymes
General approach in the development of commercially useful enzymes using
extremophile sources:
1. Samples containing the extremophile are gathered from the extreme
environment where it is found.
2. DNA material is extracted from the extremophile and processed.
3. Macroscopic amounts of the DNA are produced using the polymerase chain
reaction.
4. The macroscopic amount of DNA is analyzed to identify the genes present that
are involved in extremozyme production.
5. Genetic engineering techniques are used to insert the extremozyme gene into
bacteria, which then produce the extremozyme.
6. The process is then commercialized.
Enzyme Inhibition
Enzyme inhibitor- is a substance that slows or stops the normal catalytic function of
an enzyme by binding to it.
-Reversible competitive inhibition
-Reversible noncompetitive inhibition
-Irreversible inhibition
Reversible Competitive Inhibition
Competitive enzyme inhibitor
-is a molecule that sufficiently resembles an enzyme-substrate in shape and
charge distribution that it can compete with the substrate for occupancy of the
enzyme’s active site.
-It decreases enzyme activity.
Reversible Competitive Inhibition
-It is a reversible process because it is maintained by weak interactions (hydrogen
bonds, etc.).
-Competitive inhibition can be reduced by simply increasing the concentration of
the substrate.
Within a
fraction of a
second, the
complex
breaks up.
The empty
active site is
then for a
navailableew
occupant.
Substrate and
inhibitor again
compete for
the empty
active site.
Reversible Competitive Inhibition
• Antihistamines
-competitive inhibitors of
histidine decarboxylation.
Reversible Noncompetitive Inhibition
Noncompetitive enzyme inhibitor
-is a molecule that decreases enzyme activity by binding to a site on an
enzyme other than the active site.
Reversible Noncompetitive Inhibition
-Lowering the concentration of a noncompetitive inhibitor sufficiently does free up
many enzymes, which then return to normal activity.
Examples:
Heavy metal ions: 𝑃𝑃𝑃𝑃 2+
, 𝐴𝐴𝐴𝐴+
, 𝐻𝐻𝐻𝐻2+
-the binding site for these ions are sulfhydryl groups (-SH) located away from
the active site.
-Metal sulfide linkages are formed, an effect that disrupts the 2nd and tertiary
structure.
Irreversible Inhibition
Irreversible enzyme inhibitor
-is a molecule that inactivates enzymes by forming a strong covalent bond
to an amino acid side-chain group at the enzyme’s active site.
-do not have structures similar to the enzyme’s normal substrate.
-The inhibitor-active site is sufficiently strong.
-Enzyme is permanently deactivated.
Example:
The actions of chemical warfare agents (nerve gases) and organophosphate
insecticides.
Prescription Drugs that Inhibit Enzyme
Activity
• ACE Inhibitors- used to treat high blood pressure conditions as well as several
heart conditions
• Two well-known families of antibiotics:
Sulfa drugs
Penicillins
ACE Inhibitors
• Angiotensin-converting enzyme
• Angiotensin is an octapeptide hormone involved in blood pressure regulation.
• Angiotensin inactive form zymogen angiotensinogen
• ACE converts the inactive decapeptide zymogen to the active octapeptide form
(angiotensin) by cleaving 2 amino acids from the zymogen structure.
ACE Inhibitors
• This medications block the action of ACE in converting angiotensinogen to
angiotensin.
• The effect of this is a lower blood pressure.
• Lisinopril- heavily prescribed for treatment of moderately elevated blood pressure
conditions.
-1-carboxy-3-phenylpropyl derivative of the dipeptide Lys-Pro.
Sulfa Drugs
• Antibacterial activity of sulfanilamide  Gerhard Domagk in 1932.
• The first antibiotics in the medical field.
• Antibiotic- is a substance that kills bacteria or inhibits their growth.
-they inhibit specific enzymes essential to the life processes of the bacteria.
Example:
Sulfanilamide inhibits bacterial growth because it is structurally similar to PABA
(p-aminobenzoic acid).
Sulfa Drugs
Penicillins
• One of the most widely used antibiotics.
• Accidentally discovered by Alexander Fleming in 1928.
Penicillins
• It inhibits transpeptidase.
-an enzyme that catalyzes the formation of peptide cross-links
between polysaccharide strands in bacterial cell walls.
• Its unique action depends on 2 aspects of enzyme deactivation:
-structural similarity to the enzyme’s natural substrate
-irreversible inhibition
• Is highly specific in binding to the active site of transpeptidase.
• Acts as a very selective competitive inhibitor.
Penicillins
• Penicillin does not usually interfere with normal metabolism in humans because of
its highly selective binding to bacterial transpeptidase.
• Penicillin an extremely useful antibiotic.
Medical Uses of Enzymes
• Enzymes can be used to diagnose certain diseases.
example: Enzyme concentrations can be useful in obtaining information
about a heart attack (blood enzyme).
Medical Uses of Enzymes
• Enzymes can be used in the treatment of diseases.
example: Tissue plasminogen activator (TPA)
• Enzymes used for chemical analysis in the clinical laboratory.
example: Blood urea nitrogen test (BUN)
Chapter_4__Enzymes_and_Vitamins__Enzymes_part_2_.pdf.pdf

More Related Content

Similar to Chapter_4__Enzymes_and_Vitamins__Enzymes_part_2_.pdf.pdf

العوامل المؤثرة على التفاعلات الانزيمية
العوامل المؤثرة على التفاعلات الانزيميةالعوامل المؤثرة على التفاعلات الانزيمية
العوامل المؤثرة على التفاعلات الانزيمية
Mohamed Hassanien
 
Enzymes
EnzymesEnzymes
Enzymes
kinjal2112
 
Enzymes and enzymes inhibition, GPCR
Enzymes and enzymes inhibition, GPCREnzymes and enzymes inhibition, GPCR
Enzymes and enzymes inhibition, GPCR
AbhishekJoshi312
 
Enzymes lect.-ppt
Enzymes lect.-pptEnzymes lect.-ppt
Enzymes lect.-ppt
Namita Batra
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
AlyssaMaeAzarcon
 
Unit 4: Plasma Enzyme tests in diagnosis
Unit 4: Plasma Enzyme tests in diagnosis Unit 4: Plasma Enzyme tests in diagnosis
Unit 4: Plasma Enzyme tests in diagnosis
DrElhamSharif
 
Enzyme
EnzymeEnzyme
Factors affecting enzyme activity SlideShare
Factors affecting enzyme activity SlideShareFactors affecting enzyme activity SlideShare
Factors affecting enzyme activity SlideShare
SAYANTA MITRA
 
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.pptEnzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
8s549jgrbm
 
Enzymes
EnzymesEnzymes
Enzymes copy
Enzymes   copyEnzymes   copy
Enzymes copy
PranayaKar
 
Artificial enzymes presentation.pptx
Artificial enzymes presentation.pptxArtificial enzymes presentation.pptx
Artificial enzymes presentation.pptx
FirujAhmed2
 
Catalysis lecture 4
Catalysis lecture 4Catalysis lecture 4
Catalysis lecture 4
Dr. Rabiul Hussain
 
ENZYMES dcm.pdf
ENZYMES dcm.pdfENZYMES dcm.pdf
ENZYMES dcm.pdf
MishiSoza
 
Grade 8 Chapter 4 Enzymes.pptx i
Grade 8 Chapter 4 Enzymes.pptx                   iGrade 8 Chapter 4 Enzymes.pptx                   i
Grade 8 Chapter 4 Enzymes.pptx i
RaeedFarshid
 
Topic 4 chapter 5 part 2 enzymes - characteristics of enzymes
Topic 4 chapter 5 part 2   enzymes - characteristics of enzymesTopic 4 chapter 5 part 2   enzymes - characteristics of enzymes
Topic 4 chapter 5 part 2 enzymes - characteristics of enzymes
Xu Jia Xian
 

Similar to Chapter_4__Enzymes_and_Vitamins__Enzymes_part_2_.pdf.pdf (20)

العوامل المؤثرة على التفاعلات الانزيمية
العوامل المؤثرة على التفاعلات الانزيميةالعوامل المؤثرة على التفاعلات الانزيمية
العوامل المؤثرة على التفاعلات الانزيمية
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes and enzymes inhibition, GPCR
Enzymes and enzymes inhibition, GPCREnzymes and enzymes inhibition, GPCR
Enzymes and enzymes inhibition, GPCR
 
Enzymes lect.-ppt
Enzymes lect.-pptEnzymes lect.-ppt
Enzymes lect.-ppt
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
 
Unit 4: Plasma Enzyme tests in diagnosis
Unit 4: Plasma Enzyme tests in diagnosis Unit 4: Plasma Enzyme tests in diagnosis
Unit 4: Plasma Enzyme tests in diagnosis
 
Enzyme
EnzymeEnzyme
Enzyme
 
Factors affecting enzyme activity SlideShare
Factors affecting enzyme activity SlideShareFactors affecting enzyme activity SlideShare
Factors affecting enzyme activity SlideShare
 
Enzyme inhibitors
Enzyme inhibitorsEnzyme inhibitors
Enzyme inhibitors
 
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.pptEnzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
Enzymology-BSc-Biochemsitry-SEM-III-PPT.pptx.ppt
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymes copy
Enzymes   copyEnzymes   copy
Enzymes copy
 
Artificial enzymes presentation.pptx
Artificial enzymes presentation.pptxArtificial enzymes presentation.pptx
Artificial enzymes presentation.pptx
 
Catalysis lecture 4
Catalysis lecture 4Catalysis lecture 4
Catalysis lecture 4
 
ENZYMES dcm.pdf
ENZYMES dcm.pdfENZYMES dcm.pdf
ENZYMES dcm.pdf
 
Enzymes
EnzymesEnzymes
Enzymes
 
Grade 8 Chapter 4 Enzymes.pptx i
Grade 8 Chapter 4 Enzymes.pptx                   iGrade 8 Chapter 4 Enzymes.pptx                   i
Grade 8 Chapter 4 Enzymes.pptx i
 
Topic 4 chapter 5 part 2 enzymes - characteristics of enzymes
Topic 4 chapter 5 part 2   enzymes - characteristics of enzymesTopic 4 chapter 5 part 2   enzymes - characteristics of enzymes
Topic 4 chapter 5 part 2 enzymes - characteristics of enzymes
 
Factors affecting enzymes
Factors affecting enzymesFactors affecting enzymes
Factors affecting enzymes
 
Enzymes. classification. isoenzymes
Enzymes. classification. isoenzymesEnzymes. classification. isoenzymes
Enzymes. classification. isoenzymes
 

More from miyamoto Musashi

Red Orange Print Style Bayaning Pilipino PH Presentation.pptx
Red Orange Print Style Bayaning Pilipino PH Presentation.pptxRed Orange Print Style Bayaning Pilipino PH Presentation.pptx
Red Orange Print Style Bayaning Pilipino PH Presentation.pptx
miyamoto Musashi
 
Identifying of Pre-referral Treatment.ppt
Identifying of Pre-referral Treatment.pptIdentifying of Pre-referral Treatment.ppt
Identifying of Pre-referral Treatment.ppt
miyamoto Musashi
 
laos police system, president,locationppt.pptx
laos police system, president,locationppt.pptxlaos police system, president,locationppt.pptx
laos police system, president,locationppt.pptx
miyamoto Musashi
 
POSITIONING-A-PATIENT-IN-BED.pptx
POSITIONING-A-PATIENT-IN-BED.pptxPOSITIONING-A-PATIENT-IN-BED.pptx
POSITIONING-A-PATIENT-IN-BED.pptx
miyamoto Musashi
 
Protein-Metabolism.pptx
Protein-Metabolism.pptxProtein-Metabolism.pptx
Protein-Metabolism.pptx
miyamoto Musashi
 
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.pptpdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
miyamoto Musashi
 
14.0 The Lymphatic System.pdf
14.0 The Lymphatic System.pdf14.0 The Lymphatic System.pdf
14.0 The Lymphatic System.pdf
miyamoto Musashi
 
05 The Skeletal System - Bone Tissue (1).pdf
05 The Skeletal System - Bone Tissue (1).pdf05 The Skeletal System - Bone Tissue (1).pdf
05 The Skeletal System - Bone Tissue (1).pdf
miyamoto Musashi
 
12.0 The Endocrine System.pdf
12.0 The Endocrine System.pdf12.0 The Endocrine System.pdf
12.0 The Endocrine System.pdf
miyamoto Musashi
 
07 The Skeletal System - Appendicular Skeleton.pdf
07 The Skeletal System - Appendicular Skeleton.pdf07 The Skeletal System - Appendicular Skeleton.pdf
07 The Skeletal System - Appendicular Skeleton.pdf
miyamoto Musashi
 
08 The Skeletal System - Joints (1).pdf
08 The Skeletal System - Joints (1).pdf08 The Skeletal System - Joints (1).pdf
08 The Skeletal System - Joints (1).pdf
miyamoto Musashi
 
09 The Muscular System.pdf
09 The Muscular System.pdf09 The Muscular System.pdf
09 The Muscular System.pdf
miyamoto Musashi
 

More from miyamoto Musashi (12)

Red Orange Print Style Bayaning Pilipino PH Presentation.pptx
Red Orange Print Style Bayaning Pilipino PH Presentation.pptxRed Orange Print Style Bayaning Pilipino PH Presentation.pptx
Red Orange Print Style Bayaning Pilipino PH Presentation.pptx
 
Identifying of Pre-referral Treatment.ppt
Identifying of Pre-referral Treatment.pptIdentifying of Pre-referral Treatment.ppt
Identifying of Pre-referral Treatment.ppt
 
laos police system, president,locationppt.pptx
laos police system, president,locationppt.pptxlaos police system, president,locationppt.pptx
laos police system, president,locationppt.pptx
 
POSITIONING-A-PATIENT-IN-BED.pptx
POSITIONING-A-PATIENT-IN-BED.pptxPOSITIONING-A-PATIENT-IN-BED.pptx
POSITIONING-A-PATIENT-IN-BED.pptx
 
Protein-Metabolism.pptx
Protein-Metabolism.pptxProtein-Metabolism.pptx
Protein-Metabolism.pptx
 
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.pptpdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
pdfslide.net_-parts-of-the-skeletal-system-bones-skeleton-joints-cartilages.ppt
 
14.0 The Lymphatic System.pdf
14.0 The Lymphatic System.pdf14.0 The Lymphatic System.pdf
14.0 The Lymphatic System.pdf
 
05 The Skeletal System - Bone Tissue (1).pdf
05 The Skeletal System - Bone Tissue (1).pdf05 The Skeletal System - Bone Tissue (1).pdf
05 The Skeletal System - Bone Tissue (1).pdf
 
12.0 The Endocrine System.pdf
12.0 The Endocrine System.pdf12.0 The Endocrine System.pdf
12.0 The Endocrine System.pdf
 
07 The Skeletal System - Appendicular Skeleton.pdf
07 The Skeletal System - Appendicular Skeleton.pdf07 The Skeletal System - Appendicular Skeleton.pdf
07 The Skeletal System - Appendicular Skeleton.pdf
 
08 The Skeletal System - Joints (1).pdf
08 The Skeletal System - Joints (1).pdf08 The Skeletal System - Joints (1).pdf
08 The Skeletal System - Joints (1).pdf
 
09 The Muscular System.pdf
09 The Muscular System.pdf09 The Muscular System.pdf
09 The Muscular System.pdf
 

Recently uploaded

ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 

Recently uploaded (20)

ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 

Chapter_4__Enzymes_and_Vitamins__Enzymes_part_2_.pdf.pdf

  • 1. Chapter 4- Enzymes and Vitamins (Part B of Enzymes) JEMIMAH JOY I. GUARIN
  • 2. Part B: • Factors that affect enzyme activity • Extremozymes • Enzyme Inhibition • Prescription Drugs that Inhibit Enzyme Activity • Medical Uses of Enzymes
  • 3. Factors that Affect Enzyme Activity Enzyme activity- is a measure of the rate at which an enzyme converts the substrate to products in a biochemical reaction. • Temperature • pH • Substrate concentration • Enzyme concentration
  • 4. Temperature temperature  molecules are moving faster and colliding more frequently. temperature of an enzymatically catalyzed reaction; the rate (velocity) of the reaction
  • 5. Temperature • Temperature increases beyond a certain point, and the increased energy begins to cause disruptions in the tertiary structure of the enzyme  enzyme denaturation. • Change in tertiary structure at the active site impedes catalytic action, and the enzyme activity quickly decreases as the temperature climbs past this point. • Optimum temperature- is the temperature at which an enzyme exhibits maximum activity.
  • 6. Temperature Example: Human enzymes the optimum temperature is 37°C. -If it exceeds 40°C, it can be a life-threatening situation because such a temperature is sufficient to initiate enzyme denaturation. Autoclaves- a high temperature, high-pressure vessels Wherein super-heated stem is used to produce a Temperature is sufficient to denature bacterial enzymes.
  • 7. pH • The pH of an enzyme’s environment can affect its activity. • Small changes in pH can result in enzyme denaturation and subsequent loss of catalytic activity. • Most enzymes exhibit maximum activity over a very narrow pH range. • Optimum pH- is the pH at which an enzyme exhibits maximum activity. • Biochemical buffers help maintain the optimum pH for an enzyme. • Enzyme physiological pH range: 7.0-7.5 • Exception: the digestive enzymes pepsin=2.0 ; trypsin=8.0 • A variation from normal pH can also affect substrates, causing either Protonation or deprotonation of groups on the substrate.
  • 8. Substrate Concentration • Saturation curve- is when the concentration of an enzyme is kept constant and the concentration of substrate is increased. • Each substrate must occupy an enzyme active site for a finite amount of time, and the products must leave the site before the cycle can be repeated. • Turnover number- is the number of substrate molecules transformed per minute by one molecule of enzyme under optimum conditions of temperature, pH, and saturation.
  • 9. Enzyme Concentration • The concentration of substrate in a reaction is much higher than that of the enzyme. • The greater the enzyme concentration, the greater the reaction rate.
  • 10.
  • 11. Extremozymes • Extremophile - is a microorganism that thrives in extreme environments, environments in which humans and most other forms of life could not survive. -comes from the Latin words: extremus extreme; philia love • The ability of extremophiles to survive under such harsh conditions is related to the amino acid sequences present in the enzymes (proteins) of extremophiles.
  • 12. Extremozymes Types of Extremophiles: Acidophiles- optimal growth at pH levels of 3.0 or below. Alkaliphiles- optimal growth at pH levels of 9.0 or above. Halophiles- high salinity, a salinity that exceeds 0.2 M NaCl needed for growth. Hyperthermophiles- a temperature between 80°C and 121°C needed to thrive. Piezophiles- a high hydrostatic pressure needed for growth. Xerophiles- extremely dry conditions needed for growth. Cryophiles- a temperature of 15°C or lower needed for growth.
  • 13. Extremozymes -is a microbial enzyme active at conditions that would inactivate human enzymes as well as enzymes present in other types of higher organisms.
  • 14. Extremozymes General approach in the development of commercially useful enzymes using extremophile sources: 1. Samples containing the extremophile are gathered from the extreme environment where it is found. 2. DNA material is extracted from the extremophile and processed. 3. Macroscopic amounts of the DNA are produced using the polymerase chain reaction. 4. The macroscopic amount of DNA is analyzed to identify the genes present that are involved in extremozyme production. 5. Genetic engineering techniques are used to insert the extremozyme gene into bacteria, which then produce the extremozyme. 6. The process is then commercialized.
  • 15. Enzyme Inhibition Enzyme inhibitor- is a substance that slows or stops the normal catalytic function of an enzyme by binding to it. -Reversible competitive inhibition -Reversible noncompetitive inhibition -Irreversible inhibition
  • 16. Reversible Competitive Inhibition Competitive enzyme inhibitor -is a molecule that sufficiently resembles an enzyme-substrate in shape and charge distribution that it can compete with the substrate for occupancy of the enzyme’s active site. -It decreases enzyme activity.
  • 17. Reversible Competitive Inhibition -It is a reversible process because it is maintained by weak interactions (hydrogen bonds, etc.). -Competitive inhibition can be reduced by simply increasing the concentration of the substrate. Within a fraction of a second, the complex breaks up. The empty active site is then for a navailableew occupant. Substrate and inhibitor again compete for the empty active site.
  • 18. Reversible Competitive Inhibition • Antihistamines -competitive inhibitors of histidine decarboxylation.
  • 19. Reversible Noncompetitive Inhibition Noncompetitive enzyme inhibitor -is a molecule that decreases enzyme activity by binding to a site on an enzyme other than the active site.
  • 20. Reversible Noncompetitive Inhibition -Lowering the concentration of a noncompetitive inhibitor sufficiently does free up many enzymes, which then return to normal activity. Examples: Heavy metal ions: 𝑃𝑃𝑃𝑃 2+ , 𝐴𝐴𝐴𝐴+ , 𝐻𝐻𝐻𝐻2+ -the binding site for these ions are sulfhydryl groups (-SH) located away from the active site. -Metal sulfide linkages are formed, an effect that disrupts the 2nd and tertiary structure.
  • 21. Irreversible Inhibition Irreversible enzyme inhibitor -is a molecule that inactivates enzymes by forming a strong covalent bond to an amino acid side-chain group at the enzyme’s active site. -do not have structures similar to the enzyme’s normal substrate. -The inhibitor-active site is sufficiently strong. -Enzyme is permanently deactivated. Example: The actions of chemical warfare agents (nerve gases) and organophosphate insecticides.
  • 22.
  • 23. Prescription Drugs that Inhibit Enzyme Activity • ACE Inhibitors- used to treat high blood pressure conditions as well as several heart conditions • Two well-known families of antibiotics: Sulfa drugs Penicillins
  • 24. ACE Inhibitors • Angiotensin-converting enzyme • Angiotensin is an octapeptide hormone involved in blood pressure regulation. • Angiotensin inactive form zymogen angiotensinogen • ACE converts the inactive decapeptide zymogen to the active octapeptide form (angiotensin) by cleaving 2 amino acids from the zymogen structure.
  • 25. ACE Inhibitors • This medications block the action of ACE in converting angiotensinogen to angiotensin. • The effect of this is a lower blood pressure. • Lisinopril- heavily prescribed for treatment of moderately elevated blood pressure conditions. -1-carboxy-3-phenylpropyl derivative of the dipeptide Lys-Pro.
  • 26. Sulfa Drugs • Antibacterial activity of sulfanilamide  Gerhard Domagk in 1932. • The first antibiotics in the medical field. • Antibiotic- is a substance that kills bacteria or inhibits their growth. -they inhibit specific enzymes essential to the life processes of the bacteria. Example: Sulfanilamide inhibits bacterial growth because it is structurally similar to PABA (p-aminobenzoic acid).
  • 28. Penicillins • One of the most widely used antibiotics. • Accidentally discovered by Alexander Fleming in 1928.
  • 29. Penicillins • It inhibits transpeptidase. -an enzyme that catalyzes the formation of peptide cross-links between polysaccharide strands in bacterial cell walls. • Its unique action depends on 2 aspects of enzyme deactivation: -structural similarity to the enzyme’s natural substrate -irreversible inhibition • Is highly specific in binding to the active site of transpeptidase. • Acts as a very selective competitive inhibitor.
  • 30. Penicillins • Penicillin does not usually interfere with normal metabolism in humans because of its highly selective binding to bacterial transpeptidase. • Penicillin an extremely useful antibiotic.
  • 31. Medical Uses of Enzymes • Enzymes can be used to diagnose certain diseases. example: Enzyme concentrations can be useful in obtaining information about a heart attack (blood enzyme).
  • 32. Medical Uses of Enzymes • Enzymes can be used in the treatment of diseases. example: Tissue plasminogen activator (TPA) • Enzymes used for chemical analysis in the clinical laboratory. example: Blood urea nitrogen test (BUN)